Skip to Main Content

Paper Details

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.
NPJ Breast Cancer
4
2021
Breast Cancer, Participants, Women, participants, raloxifene, tamoxifen, women
Author NameAffiliation
Robert A HiattUniversity of California san francisco
Robert A HiattUniversity of California san francisco
Lisa MadlenskyUniversity of California
Elad ZivUniversity of California san francisco
Elad ZivUniversity of California san francisco
Hoda Anton-CulverUniversity of California irvine
Hoda Anton-CulverUniversity of California irvine
Alexander D BorowskyUniversity of California davis
Alexander D BorowskyUniversity of California davis
Arash NaeimUniversity of California los angeles
Laura J Van't VeerUniversity of California san francisco
  • 1 - 11

Datasets